Literature DB >> 1718697

The pathophysiology and epidemiology of myocardial infarction. A review.

J Gill1.   

Abstract

Myocardial infarction continues to represent a major cause of death in the Western world, and although there have been significant reductions in its incidence in recent years, some countries such as Scotland and Finland still have high mortality rates. Thrombotic occlusion, in association with varying degrees of plaque disruption and coronary artery spasm, represents the major cause of acute myocardial infarction (AMI). At the cellular level, this results in a shift towards anaerobic metabolism, depletion of energy stores, disrupted membrane integrity, alterations in ionic gradients, myocyte oedema, inhibition of contraction and a proarrhythmic potential. Reperfusion can exacerbate the damage, producing calcium ion accumulation and free radical generation. Infarct expansion and ventricular remodelling can often follow AMI as can additional necrosis, in the form of infarct extension/reinfarction. Rational and optimal treatment of AMI should be based on an understanding of the epidemiological influences and the pathophysiological processes involved. This review considers some of the important features in the pre-, peri- and postinfarction periods.

Entities:  

Mesh:

Year:  1991        PMID: 1718697     DOI: 10.2165/00003495-199100422-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  55 in total

Review 1.  Pathophysiology of acute myocardial infarction: a rationale for thrombolytic therapy.

Authors:  M Misinski
Journal:  Heart Lung       Date:  1988-11       Impact factor: 2.210

Review 2.  Free radicals in acute myocardial infarction.

Authors:  A J Larner; M A Conway
Journal:  Q J Med       Date:  1989-03

3.  Coronary thrombosis, coronary spasm and coronary atherosclerosis and speculation on the link between unstable angina and acute myocardial infarction.

Authors:  R L Feldman
Journal:  Am J Cardiol       Date:  1987-05-01       Impact factor: 2.778

4.  Low vitamin B6 status in patients with acute myocardial infarction.

Authors:  F J Kok; J Schrijver; A Hofman; J C Witteman; D A Kruyssen; W J Remme; H A Valkenburg
Journal:  Am J Cardiol       Date:  1989-03-01       Impact factor: 2.778

Review 5.  Silent myocardial ischemia.

Authors:  S C Hammill; B K Khandheria
Journal:  Mayo Clin Proc       Date:  1990-03       Impact factor: 7.616

Review 6.  Acute myocardial ischemia: role of atherosclerosis, thrombosis, platelet activation, coronary vasospasm, and altered arachidonic acid metabolism.

Authors:  C R Conti; J L Mehta
Journal:  Circulation       Date:  1987-06       Impact factor: 29.690

Review 7.  New perspectives on the function of coronary artery spasm in acute myocardial infarction: the thromboischemic reentry mechanism. A review of 10 years research on the pathophysiology of AMI.

Authors:  R N Gasser; F Dienstl; B Puschendorf; S Hauptlorenz; M Moll; E Dworzak
Journal:  Angiology       Date:  1986-12       Impact factor: 3.619

Review 8.  Pathophysiology of coronary occlusion in acute infarction.

Authors:  A Maseri; S Chierchia; G Davies
Journal:  Circulation       Date:  1986-02       Impact factor: 29.690

9.  Acute myocardial infarct extension into a previously preserved subendocardial region at risk in dogs and patients.

Authors:  R Forman; S Cho; S M Factor; E S Kirk
Journal:  Circulation       Date:  1983-01       Impact factor: 29.690

10.  Coronary atherosclerosis and myocardial infarction in autopsied patients in Gondar, Ethiopia.

Authors:  M Maru
Journal:  J R Soc Med       Date:  1989-07       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.